Development of Digital PCR Diagnostic Assay for Infectious diseases.

Development of Digital PCR Diagnostic Assay for Infectious diseases. - Development of Digital PCR Diagnostic Assay for Infectious diseases.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016464

Enrollment

Registered

2015-02-06

Start date

2015-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycobacterium tubeculosis infection Pneumocystis pneumoniae

Interventions

Conducting Digital PCR assay targeting the pathogenic microorganism specific genes using purified DNA from blood or other body fluid samples.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals with active TB infection who are planned to start on anti-tuberculosis chemotherapy and have capability of informed consent. Individuals with or suspected with pneumocystis pneumonia who have capability of informed consent.

Exclusion criteria

Exclusion criteria: Individuals without capability of informed consent.

Design outcomes

Primary

Measure	Time frame
Consistency with existing diagnostic methods	—

Countries

Japan

Contacts

Public ContactMasaki Yamamoto

Graduate School of Medicine, Yokohama City University Department of Respirology

masakiy@yokohama-cu.ac.jp045-787-2630

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026